Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3549805 | 1.00 | TSHR (0.31) | TSHRLMNA | |
| SCHEMBL6133165 | 1.00 | TSHR (0.31) | TSHRLMNA | |
| SCHEMBL28455957 | 0.83 | TSHR (0.31) | TSHR | |
| SCHEMBL12374922 | 0.82 | — | — | |
| SCHEMBL5880313 | 0.81 | TSHR (0.32) | TSHR | |
| SCHEMBL3767455 | 0.81 | TSHR (0.32) | TSHR | |
| SCHEMBL3767458 | 0.81 | TSHR (0.32) | TSHR | |
| SCHEMBL9482960 | 0.80 | MGAM (0.37) | TSHR | |
| SCHEMBL28439843 | 0.80 | MGAM (0.37) | TSHR | |
| SCHEMBL9482958 | 0.80 | MGAM (0.37) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111171051-B | Preparation method of cefixime | 山西阳和医药技术有限公司 | 2021-09-10 | — | — | CN | claimed |
| CN-111171051-A | Preparation method of cefixime | 张炳哲 | 2020-05-19 | — | — | CN | claimed |
| EP-0191507-B1 | NEW 2-OXYIMINO-3-OXOBUTYRIC ACID DERIVATIVES AND PROCESS FOR PREPARATION THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-05-16 | — | — | EP | claimed |
| EP-0191507-A2 | New 2-oxyimino-3-oxobutyric acid derivatives and process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-08-20 | — | — | EP | claimed |
| JP-58135894-A | — | — | None | — | — | JP | disclosed |
| CN-111171051-B | Preparation method of cefixime | 山西阳和医药技术有限公司 | 2021-09-10 | — | — | CN | disclosed |
| CN-111171051-A | Preparation method of cefixime | 张炳哲 | 2020-05-19 | — | — | CN | disclosed |
| CN-103265562-A | Preparation method of cefixime | SICHUAN DIRECTION PHARMACEUTICAL CO LTD | 2013-08-28 | — | — | CN | disclosed |
| US-7705142-B2 | Process for the preparation of cefixime | HETERO DRUGS LIMITED (IN) | 2010-04-27 | — | — | US | disclosed |
| EP-1863822-B1 | AN IMPROVED PROCESS FOR THE PREPARATION OF CEFIXIME | HETERO DRUGS LTD (IN) | 2009-10-14 | — | — | EP | disclosed |
| US-20080242858-A1 | Process For the Preparation of Cefixime | HETERO DRUGS LIMITED (IN) | 2008-10-02 | — | — | US | disclosed |
| EP-1863822-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF CEFIXIME | Hetero Drugs Limited (IN) | 2007-12-12 | — | — | EP | disclosed |
| EP-0191507-B1 | NEW 2-OXYIMINO-3-OXOBUTYRIC ACID DERIVATIVES AND PROCESS FOR PREPARATION THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-05-16 | — | — | EP | disclosed |
| EP-0057422-B1 | NEW CEPHEM COMPOUNDS, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-10-12 | — | — | EP | disclosed |
| US-4731443-A | 7-acylamino-3-vinylcephalosporanic acid derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-03-15 | — | — | US | disclosed |
| EP-0191507-A2 | New 2-oxyimino-3-oxobutyric acid derivatives and process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-08-20 | — | — | EP | disclosed |
| US-4487927-A | BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-12-11 | — | — | US | disclosed |
| US-4452851-A | BACTERICIDES, ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-06-05 | — | — | US | disclosed |
| JP-S58135894-A | 7-ACYLAMINO-3-VINYLCEPHALOSPORANIC ACID DERIVATIVE AND ITS PREPARATION | FUJISAWA PHARMACEUT CO LTD | 1983-08-12 | — | — | JP | disclosed |
| EP-0057422-A2 | New cephem compounds, processes for preparation thereof and pharmaceutical composition containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242858-A1 | Process For the Preparation of Cefixime | ACMSD, HAAO, HDHD5 | TSHR 4367/4885LMNA 4102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.